Consolidated Statements of Operations - USD ($)	12 Months Ended
	Jan. 31, 2019	Jan. 31, 2018
Income Statement [Abstract]
Sales - net of slotting fees and discounts	$ 28,522,112	$ 27,543,335
Cost of sales	18,531,678	18,282,660
Gross profit	9,990,434	9,260,675
Operating expenses
Research and development	130,920	138,000
General and administrative	8,294,450	8,059,533
Total operating expenses	8,425,370	8,197,533
Income from operations	1,565,064	1,063,142
Other expenses
Interest	(881,702)	(679,974)
Amortization of debt discount	(133,314)	(63,428)
Total other expenses	(1,015,016)	(743,402)
Net income	550,048	319,740
Less: preferred dividends		(91,565)
Net income (loss) available to common stockholders	$ 550,048	$ 228,175
Net income (loss) per common share - basic and diluted	$ 0.02	$ 0.01
Weighted average common shares outstanding - basic	31,843,755	29,811,521
Weighted average common shares outstanding - diluted	32,521,821	32,205,577